Ingles Markets declares cash dividends
ASHEVILLE, N.C. — The board of directors at Ingles Markets have declared cash dividends on all of its class A common stock and class B common stock.
A cash dividend of 16.5 cents was declared for the chain’s class A common stock, while 15 cents per share was declared for its class B common stock. This is an annual rate of 66 cents and 60 cents per share, respectively.
Dividends on both the class A and class B common stock are payable July 19 to all shareholders of record on July 5.
Lee Stafford introduces summer hair care line
NEW YORK — Lee Stafford, the British celebrity hair stylist whose line made its U.S. debut last month, is showcasing the brand’s summer hair care items.
The lineup includes:
Beach Babe sea salt spray: Helping to create the the tousled, textured look of sea doused, beach dried hair, this spray features a ProMineral complex, containing Dead Sea salts and 26 minerals, makes hair look and feel soft with added bounce, definition and body. The spray also features sunflower extract, which is designed to give hair moisture and shine, and protects it against free radicals. The spray carries a suggested retail price of $11.99.
Poker Straight dehumidifier: this weightless spray protects hair from frizz-causing humidity and adds beautiful shine to styled hair. The spray carries a suggested retail price of $8.49.
Bleach Blonde shampoo/conditioner: This moisturizing shampoo and conditioner are designed to combat the summer’s wrath to keep blonde hair bright, fresh and healthy. The shampoo and conditioner carry a suggested retail price of $9.99 each.
Hair growth treatment: This scalp refining, moisture balancing deep treatment contains angeline, a hair growth stimulating protein, Angeline. In addition to supporting growth of long, flowing strands, this treatment also is beneficial for those struggling with dry and damaged hair from the extreme summer conditions. The hair growth treatment carries a suggested retail price of $14.99.
Lee Stafford hair care products are available at Duane Reade stores, Ulta and Ulta.com.
FDA approves Actavis ADHD drug
MORRISTOWN, N.J. — The Food and Drug Administration has approved a generic drug for attention deficit hyperactivity disorder made by Actavis, the drug maker said Monday.
Actavis, whose parent company was recently acquired by Watson Pharmaceuticals, announced the approval of dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate extended-release capsules, also known as mixed-amphetamine salts ER capsules.
The drug, approved in the 5-mg, 10-mg, 15-mg, 20-mg, 25-mg and 30-mg strengths, is a generic version of Shire Adderall XR. The branded drug and generic versions had sales of $1.99 billion during the 12-month period ended in March, according to IMS Health.